JP2020007333A5 - - Google Patents

Download PDF

Info

Publication number
JP2020007333A5
JP2020007333A5 JP2019153406A JP2019153406A JP2020007333A5 JP 2020007333 A5 JP2020007333 A5 JP 2020007333A5 JP 2019153406 A JP2019153406 A JP 2019153406A JP 2019153406 A JP2019153406 A JP 2019153406A JP 2020007333 A5 JP2020007333 A5 JP 2020007333A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
patient
signal
glyx
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019153406A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020007333A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020007333A publication Critical patent/JP2020007333A/ja
Publication of JP2020007333A5 publication Critical patent/JP2020007333A5/ja
Pending legal-status Critical Current

Links

JP2019153406A 2013-12-13 2019-08-26 脳障害を治療する、またはそれに関連した生物マーカーを同定する方法 Pending JP2020007333A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361915835P 2013-12-13 2013-12-13
US61/915,835 2013-12-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016538538A Division JP2017500306A (ja) 2013-12-13 2014-12-15 脳障害を治療する、またはそれに関連した生物マーカーを同定する方法

Publications (2)

Publication Number Publication Date
JP2020007333A JP2020007333A (ja) 2020-01-16
JP2020007333A5 true JP2020007333A5 (https=) 2020-07-27

Family

ID=53371976

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016538538A Pending JP2017500306A (ja) 2013-12-13 2014-12-15 脳障害を治療する、またはそれに関連した生物マーカーを同定する方法
JP2019153406A Pending JP2020007333A (ja) 2013-12-13 2019-08-26 脳障害を治療する、またはそれに関連した生物マーカーを同定する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016538538A Pending JP2017500306A (ja) 2013-12-13 2014-12-15 脳障害を治療する、またはそれに関連した生物マーカーを同定する方法

Country Status (9)

Country Link
US (1) US20160345855A1 (https=)
EP (2) EP3079579A4 (https=)
JP (2) JP2017500306A (https=)
CN (2) CN106102762A (https=)
AU (2) AU2014361822A1 (https=)
CA (1) CA2933372A1 (https=)
IL (2) IL246148A0 (https=)
MX (1) MX2016007716A (https=)
WO (1) WO2015089503A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018530593A (ja) * 2015-10-16 2018-10-18 ノースウェスタン ユニバーシティ 統合失調症、双極性障害、認知障害及び大うつ病性障害の治療のための非定型的抗精神病薬ならびにnmda調節剤の医薬品の組み合わせ
US20220024976A1 (en) * 2019-01-11 2022-01-27 Naurex Inc. Salt and crystalline forms of rapastinel
CN110123342B (zh) * 2019-04-17 2021-06-08 西北大学 一种基于脑电波的网瘾检测方法及系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
US20050273017A1 (en) * 2004-03-26 2005-12-08 Evian Gordon Collective brain measurement system and method
US20090253982A1 (en) * 2006-04-03 2009-10-08 Jiongjiong Wang Assessing subject's reactivity to psychological stress using fmri
CN101505745A (zh) * 2006-06-15 2009-08-12 玛尔斯有限公司 改善认知功能的方法和组合物
US8951968B2 (en) * 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
PL2485751T3 (pl) * 2009-10-05 2014-10-31 Univ Northwestern GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie
US20140107037A1 (en) * 2011-04-27 2014-04-17 Northwestern University Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
WO2013106084A1 (en) * 2012-01-09 2013-07-18 Takeda Pharmaceutical Company Limited Methods and drug products for treating alzheimer's disease

Similar Documents

Publication Publication Date Title
Cantone et al. Cortical plasticity in depression: a neurochemical perspective from transcranial magnetic stimulation
Tse et al. The effect of stimulation interval on plasticity following repeated blocks of intermittent theta burst stimulation
Young et al. Changes in functional connectivity correlate with behavioral gains in stroke patients after therapy using a brain-computer interface device
Koszewicz et al. The characteristics of autonomic nervous system disorders in burning mouth syndrome and Parkinson disease
Atagün et al. Decrease of event-related delta oscillations in euthymic patients with bipolar disorder
Lee et al. Targeting neural synchrony deficits is sufficient to improve cognition in a schizophrenia-related neurodevelopmental model
JP2020007333A5 (https=)
Mun-Bryce et al. Recurring episodes of spreading depression are spontaneously elicited by an intracerebral hemorrhage in the swine
André et al. Rapid eye movement sleep, neurodegeneration, and amyloid deposition in aging
Keplinger et al. Effective local anaesthetic volumes for sciatic nerve blockade: a clinical evaluation of the ED99
Abraham et al. Fatigue in motor neuron diseases
Elvsåshagen et al. Evidence for impaired neocortical synaptic plasticity in bipolar II disorder
Wang et al. Neuroprotective effect of microglia against impairments of auditory steady-state response induced by anti-P IgG from SLE patients in naïve mice
Avenali et al. Clinical and electrophysiological outcome measures of patients with post-infectious neurological syndromes related to COVID-19 treated with intensive neurorehabilitation
D’Rozario et al. Region-specific changes in brain activity and memory after continuous positive airway pressure therapy in obstructive sleep apnea: a pilot high-density electroencephalography study
Yu et al. The electrophysiological and neuropathological profiles of cerebellum in APPswe/PS1ΔE9 mice: a hypothesis on the role of cerebellum in Alzheimer's disease
Benuzzi et al. Recovery from emotion recognition impairment after temporal lobectomy
JP2009521403A (ja) Mriによる神経発生の相関の画像法
Lucey Sleep alterations and cognitive decline
Gee et al. An updated Barnes maze protocol for assessing the outcome of controlled cortical impact mouse models of traumatic brain injury
Mathur et al. Coma, disorders of consciousness, and brain death
Li et al. Aberrant auditory steady-state response of awake mice induced by chronic interferon-α treatment
Saponjic et al. Sleep-state related EEG amplitude distribution in the rat model of cortical cholinergic innervation disorder
JP2017500306A5 (https=)
Yoo et al. Repeated application of transcranial ultrasound maintains spatial and recognition memory in 5xFAD mice with reduction of amyloid-β burden